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Abstract
Background & aims
Ingestion of poorly digested, fermentable carbohydrates (fermentable oligo-, di-, mono-sac-
charides and polyols; FODMAPs) have been implicated in exacerbating intestinal symptoms
and the reduction of intake with symptom alleviation. Restricting FODMAP intake is believed
to relieve colonic distension by reducing colonic fermentation but this has not been previ-
ously directly assessed. We performed a randomised controlled trial comparing the effect of
a low FODMAP diet combined with either maltodextrin or oligofructose on colonic contents,
metabolites and microbiota.
Methods
A parallel randomised controlled trial in healthy adults (n = 37). All subjects followed a low
FODMAP diet for a week and supplemented their diet with either maltodextrin (MD) or oligo-
fructose (OF) 7g twice daily. Fasted assessments performed pre- and post-diet included
MRI to assess colonic volume, breath testing for hydrogen and methane, and stool collec-
tion for microbiota analysis.
Results
The low FODMAP diet was associated with a reduction in Bifidobacterium and breath hydro-
gen, which was reversed by oligofructose supplementation. The difference in breath
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hydrogen between groups post-intervention was 27ppm (95% CI 7 to 50, P<0.01). Colonic
volume increased significantly from baseline in both groups (OF increased 110ml (19.6%),
95% CI 30ml to 190ml, P = 0.01; MD increased 90ml (15.5%), 95% CI 6ml to 175ml, P =
0.04) with no significant difference between them. Colonic volumes correlated with total
breath hydrogen + methane. A divergence in Clostridiales abundance was observed with
increased abundance of Ruminococcaceae in the maltodextrin group, while in the oligofruc-
tose group, Lachnospiraceae decreased. Subjects in either group with high methane pro-
duction also tended to have high microbial diversity, high colonic volume and greater
abundance of methanogens.
Conclusion
A low FODMAP diet reduces total bacterial count and gas production with little effect on
colonic volume.
Introduction
Poorly digested, fermentable carbohydrates are believed to contribute to a healthy diet. Inges-
tion of ‘prebiotics’ that preferentially stimulate colonic bacteria[1], such as oligofructose and
inulin, has been shown to reduce markers of metabolic syndrome while increasing the abun-
dance of Bifidobacteria[2] and butyrate producers[3–5]. However intake of prebiotics may be
limited by GI symptoms such as bloating, flatulence and abdominal discomfort[6]. These com-
plex carbohydrates have been grouped as fermentable oligo-, di-, mono-saccharides and poly-
ols (FODMAPs)[7] and dietary FODMAP restriction has been shown to relieve IBS symptoms
[8–11]. A typical UK diet contains on average 29.6 g of FODMAPs the single largest compo-
nent being fructose, either monomeric or as fructans, which averages 16.6 g / day while a typi-
cal patient following dietary advice for a low FODMAP diet reduces approximately by half to a
total of 17.7 g of FODMAP [12].
Low FODMAP diets have raised concerns as they can alter the microbiota towards an unde-
sired composition. These changes include a reduction in health beneficial Bifidobacteria[12–
14] and Clostridial species producing SCFAs as well as an increase in bacteria such as Rumino-
coccus torques, previously associated with IBS[15]. This patient group has been shown to have
a dysbiotic microbiota[16] and further compromising the composition raises concern.
Testing for the complex interactions between microbiota and intestinal physiology has
been limited by the lack of appropriate and non-invasive techniques. MRI of the gut allows
non-invasive assessment of luminal content. We have previously demonstrated that it provides
a simple and reproducible method for measuring colonic volume and whole gut transit[17,
18]. GI transit and microbiota composition were found to be interrelated in a humanized
mouse model, with diet independently affecting both[19]. While conversion of FODMAPs to
colonic gas by fermentative bacteria may be an important mediator of symptom development,
it is unclear whether breath gas excretion is a good marker of colonic gas production and dis-
tension[20]. In a controlled, crossover feeding study with both IBS and healthy subjects, it was
demonstrated that a high FODMAP diet increased breath hydrogen production compared to a
diet low in FODMAPs in both healthy and IBS patients[21].
Thus far there are no studies of the effect of low FODMAPs on colonic volumes, metabo-
lites and microbiota in healthy subjects. Therefore our aim was to understand the impact of a
FODMAPs, microbiota and colonic volume
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low FODMAP diet on colonic contents and transit and how this altered the microbiota and
their metabolites. We conducted a double-blind clinical trial where healthy subjects consumed
a low FODMAP diet and were supplemented with either maltodextrin or oligofructose daily.
We selected subjects who were not already excluding FODMAPs from their diet and who did
not have unstable microbiota. Therefore, we concentrated on healthy subjects since IBS
patients are known to have unstable and dysbiotic microbiota and GI physiology, and often
avoid foods with FODMAPs, potentially confounding the effect of a controlled intervention.
Materials & methods
The study was a single centre, parallel group, double-blind, randomised controlled trial. Ethi-
cal approval was granted by the Ethics committee of the School of Medicine, University of
Nottingham (A14082014 and Clinical Trial Registry number: NCT02259465).
Subjects
Participants were18 and gave written, informed consent prior to inclusion. Principal exclu-
sion criteria included pregnancy, inability to comply with the diet, any pre-existing gastroin-
testinal disorder or a positive diagnosis of irritable bowel syndrome based on the Rome III
questionnaire, use of antibiotics or probiotics in the preceding 8 weeks, contra-indication to
MRI scanning and use of pharmacotherapy likely to alter intestinal motility. The study CON-
SORT diagram is shown in Fig 1.
Procedures
A schematic diagram of the study is shown in Fig 2. All participants completed a 7-day food
diary. On the morning of day 7 they provided a stool sample and swallowed transit markers
for the measurement of whole gut transit time as previously validated[22]. The study dietitian
trained subjects in a low FODMAP diet. For the next 24 hours subjects were provided with a
standard food package (S1 Table). Subjects also made a 24-hour urine collection, abstained
from alcohol and did not eat after 8pm. The next morning, they underwent a fasting MRI scan
and gave a breath sample to measure hydrogen and methane content (GastroCH4eck™, Bed-
font, UK). Subjects then started a 7-day low FODMAP diet. During this time they kept a sec-
ond food diary. Stool, urine and breath collection and MRI were repeated at the end of the
diet. In the last 24 hours of the diet a standard food package specifically low in FODMAPs was
provided (S1 Table).
Randomisation and intervention
All subjects supplemented the low FODMAP diet with 14 g of the added carbohydrate (7 g
twice daily). They were randomised to either oligofructose (OraftiP95, Beneo, Germany) or
maltodextrin (the Hut Group, Northwich, UK) 1:1 in blocks of 6 using a remote, internet
based system. Randomisation was performed by staff members independent of the research
team who then dispensed over 100g of supplement of identical colour in opaque plastic con-
tainers. Containers were returned at the end of the week to assess adherence based on change
in container mass. Subjects, researchers and laboratory staff remained blind to the allocated
intervention during analysis.
Analytical methods
Nutrient and FODMAP content. Data from food diaries were analysed with Dietplan 6
P3 (Forestfield Software, Horsham, UK). Energy and nutrient intakes were based on McCance
FODMAPs, microbiota and colonic volume
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and Widdowson’s Nutrient databank (7th Edition)[23] and FODMAP intakes were calculated
from published literature (S1 Methods).
Stool microbiota. Faecal samples were stored at -80˚C before DNA extraction with a stan-
dard previously validated method[24, 25]. Amplicons of the V3-4 region of the 16S rRNA gene
were generated by PCR and sequenced with the Illumina MiSeq platform. The mare pipeline
was used for sequence pre-processing[26]. Briefly, the forward reads were quality filtered and
trimmed to a uniform length (150bp) before clustering and chimera filtering with USEARCH
[27]. Taxonomy was assigned to reads with UTAX using the Silva 16S database[28]. The total
microbial load[29] and the abundance of Methanobrevibacter smithii[30] was determined with
Fig 1. Study CONSORT diagram.
https://doi.org/10.1371/journal.pone.0201410.g001
FODMAPs, microbiota and colonic volume
PLOS ONE | https://doi.org/10.1371/journal.pone.0201410 July 26, 2018 4 / 18
qPCR as described previously. The sequencing data are publicly available in the European
Nucleotide Archive (ENA, acc.no. PRJEB25589).
Metabolomics. Urine metabolites were analysed using liquid chromatography-high reso-
lution mass spectrometry (LC-HRMS). Each sample was assigned ‘aggregate metabolite scores’
for lipids, amino acids and carbohydrates by associating peaks with potential matches in the
Human Metabolome Database (HMDB)[31] (S1 Methods).
SCFA analysis of thawed faecal samples was carried out by gas chromatography–mass spec-
trometry (GC-MS) (S1 Methods).
MRI. All scans used a 1.5T Achieva MRI scanner (Philips, Best, The Netherlands).
Colonic volume was measured as described previously[17]. Whole gut transit time was evalu-
ated using the weighted average position score (WAPS) as previously validated[22]. Auto-
mated colonic gas quantification was also attempted (S1 Methods).
Statistical analysis
Statistical analysis was performed using R version 3.2.4 (R Foundation for Statistical Comput-
ing, Vienna). Results are shown as mean (standard deviation, SD) unless otherwise stated. The
primary endpoint of the clinical trial was the effect of the intervention on the percentage
change from baseline in colonic volume. A previous 4-period crossover study in a similar pop-
ulation[18] found a coefficient of variation in fasting colonic volume of 17%. The required
sample size to detect a difference between groups of 15% was 36 (power 80%, alpha = 0.05
two-sided). A sample size of 45 was planned to allow for a withdrawal rate of 20%.
Microbiota and metabolomics data were exploratory to analyse the impact on composition
of the dietary intervention and also provide evidence of adherence. The microbiota profiles
were generated without rarefaction and analysed with package mare (Microbiota Analysis in R
Easily) [32]. Variation in read counts between samples was controlled for by taking the num-
ber of reads as an offset in all statistical models. The significant effect of study groups and the
associations between physiological variables (e.g. breath gases and colonic volume) and the
microbiota was tested using generalized linear mixed models assuming negative binomial dis-
tribution of the data, fitting to each taxon, taking into consideration that the data was zero-
inflated. This was calculated using the glmmADMB package of R. In the conducted linear
models, the subjects’ age and BMI were accounted for as confounding variables. The obtained
Fig 2. A schematic diagram of subject flow through the study.
https://doi.org/10.1371/journal.pone.0201410.g002
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p-values were corrected for multiple testing with false discovery rate (FDR, Benjamini–Hoch-
berg [33]) and adjusted p-values (adjust.P) below 0.1 were considered significant.
Results
The CONSORT flowchart is shown in Fig 1. Altogether 37 subjects completed the study. Base-
line characteristics and endpoint data for study participants in both groups are shown in
Table 1.
Dietary analysis and adherence to the intervention
No major deviations from the low FODMAP diet were identified. Daily FODMAP intake
decreased from baseline (BL) in the maltodextrin group (mean 17.7g (SD 7.4) to 1.7g (1.6),
P<0.01) while remaining constant in the oligofructose group due to the supplement, (18.9g
(8.0) to 16.5g (1.6), Fig 3A). Mean supplement compliance was 113 (21.8) % expected supple-
ment usage by weight.
Detailed analysis of the dietary intake revealed changes aside from FODMAP intake during
the intervention. For both groups reductions in mean daily carbohydrate (Fig 3B) and total
sugar were observed, but no change in fat or protein intake (S2 Table).
Urinary metabolites indicate dietary adherence. Urinary metabolic profiles provided
additional evidence of adherence with the dietary intervention. The aggregate metabolite score
for ‘carbohydrates and carbohydrate conjugates’ was reduced from baseline mean 8.2 (0.4) in
both the maltodextrin 7.9 (0.4), P<0.05 and oligofructose-groups 7.8 (0.4), P<0.01, Fig 3C,
correlating with total dietary carbohydrate intake (r = 0.38, P = 0.05). The participants’ overall
metabolic profile deviated significantly between baseline and post-intervention but there was
no significant difference between groups (S1 Fig), suggesting that the supplementation could
not cancel the effect of the diet. Aggregate metabolite scores for ‘amino acids, peptides and
Table 1. Participant characteristics and endpoints.
Maltodextrin Oligofructose
Number of subjects 18 19
Age (years) 23.5 (2.9) 26.5 (12.2)
Gender (M/F) 14/4 11/8
Height (m) 1.69 (0.09) 1.73 (0.11)
Weight (kg) 67.8 (13.6) 67.7 (10.1)
Body Mass Index (kg/ m2) 23.5 (2.9) 22.5 (2.9)
Supplement compliance (%) 104 (range 91–133) 117 (range 105–132)
BL PI p-value BL PI p-value
Total colonic Volume (ml) 650 (179) 740 (242) 0.04 693 (151) 802 (146) 0.01
ascending (ml) 219 (53) 233 (67) 0.34 238 (66) 273 (72) 0.01
transverse (ml) 259 (105) 307 (140) 0.07 273 (83) 317 (86) 0.03
distal (ml) 171 (73) 201 (87) 0.14 180 (59) 206 (52) 0.05
sigmoid 0 (0) 0 (0) - 3 (11) 8 (33) 0.33
Transit Score (a.u.) 2.09 (1.40) 2.05 (1.44) 0.82 1.51 (0.73) 1.33 (1.07) 0.24
Breath Hydrogen (ppm) 16.8 (12.8) 6.3 (6.3) 0.006 19.8 (23.4) 36.3 (32.2) 0.08
Breath Methane (ppm) 20.6 (30.5) 20.0 (33.7) 0.86 19.7 (26.1) 14.6 (26.5) 0.24
Demographic and study endpoint data for study participants. There was no statistical difference between the study groups at baseline. BL = baseline, PI = post-
intervention. Data shown as mean (SD) with no adjustment made for multiple comparisons.
https://doi.org/10.1371/journal.pone.0201410.t001
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analogues’ and ‘lipids’ were unchanged from baseline, mirroring unchanged intake of dietary
protein and fat.
Colonic volume and transit
The total colonic volume rose in the oligofructose-group by 19.6% with a mean increase of
110ml (95% CI 30ml to 190ml, P = 0.01). However, volume also increased in the maltodextrin-
group, by 15.5% with a mean increase of 90ml (95% CI 6ml to 175ml, P = 0.04, Fig 3D). When
separating these into colonic compartments there was a significant increase in the ascending
(mean 35ml, 95% CI 9ml to 61ml, P = 0.01), transverse (mean 44ml, 95% CI 4ml to 84ml,
P = 0.03) and distal colon (mean 26ml, 95% CI 0ml to 52ml, P = 0.05) only in the OF group
(Table 1). There was no significant difference between the groups. Transit scores did not
change significantly from baseline in either groups, with no significant difference between
them.
Effects of the intervention on microbiota composition
There was a significant drop in the total microbial load after the diet from baseline (11.02
log10, SD = 0.27) in both the maltodextrin-group (10.66 log10, SD = 0.40, P<0.05) and oligo-
fructose-group (10.87 log10, SD = 0.32, P<0.01, Fig 4C).
Principal coordinates analysis indicated that the microbial profiles differed post-interven-
tion between the groups, accounting for 7% of the microbial variation. Even at class level, sig-
nificant changes in the microbiota were observed in both groups (Fig 4A).
In the maltodextrin-group, a significant reduction in Actinobacteria (fold change (fc) =
0.75, FDR corrected adjusted.P<0.01) and increase in Deltaproteobacteria (fc = 2.25, adjust.
P<0.01) were observed post-intervention. These changes were driven at genus-level by a
decrease in Bifidobacterium (fc = 0.74, adjust.P = 0.19) and increase in Bilophila (fc = 2.34,
adjust.P<0.01) respectively. While the overall proportion of Clostridia was unchanged, several
Fig 3. Changes in carbohydrate intake, metabolites and colonic volume. A) Mean daily FODMAP intake (g), including oligofructose
supplementation. B) Mean daily carbohydrate intake (g), C) Aggregate metabolite score for ‘Carbohydrates and carbohydrate
conjugates’, D) Change in colonic volume post-intervention; BL = baseline, PI = post-intervention, OF = oligofructose group,
MD = maltodextrin group.  p< 0.05.
https://doi.org/10.1371/journal.pone.0201410.g003
FODMAPs, microbiota and colonic volume
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genera within the family Ruminococcaceae were increased from baseline, including Anaero-
truncus (fc = 1.77, adjust.P<0.05), Flavonifractor (fc = 2.21, P<0.01), Oscillibacter (fc = 1.85,
adjust.P = 0.05) and Oscillospira (fc = 3.07, adjust.P<0.01).
In the oligofructose-group, an increased abundance of three classes were observed; Actino-
bacteria (fc = 1.79, adjust.P<0.01), Betaproteobacteria (fc = 2.61, adjust.P<0.01) and Deltapro-
teobacteria (fc = 2.25, adjust.P<0.01), while the abundance of Clostridia (fc = 0.84, P<0.01)
and Erysipelotrichi (fc = 0.21, adjust.P<0.05) decreased. The increase in Actinobacteria was
due to an increase in Bifidobacterium (fc = 1.80, adjust.P = 0.06) while the reduction in Clos-
tridia appeared to be predominantly due to a reduction in the family Lachnospiraceae, particu-
larly Anaerostipes (fc = 0.59, adjust.P = 0.09) and Blautia (fc = 0.58, adjust.P<0.01). Within the
Deltaproteobacteria, Bilophila was increased (fc = 2.04, adjust.P = 0.1).
No significant difference was detected in the abundance or prevalence of methanogens
post-intervention in either group (BL:5.03 (2.33); maltodextrin:5.24, (2.41); oligofructose:4.66,
(2.05), copies 16S/μl of template log10). The complete list of genus-level changes following the
intervention is shown in S3 Table.
Fig 4. Changes in the microbiota from baseline with the dietary interventions. A) Significant changes at class-level;
B) Principal coordinates analysis of sample profiles at genus-level; C) Change in total bacterial count (log10/g).
BL = baseline, OF = oligofructose group, MD = maltodextrin group.  p< 0.05.
https://doi.org/10.1371/journal.pone.0201410.g004
FODMAPs, microbiota and colonic volume
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Products of metabolism and associations with the microbiota
Alterations in breath gases. The groups showed a divergent change in fasting breath
hydrogen amounts with an increase in the oligofructose group of 16ppm (95% CI -2 to 35)
after the diet and decrease in the maltodextrin group of 11ppm (95% CI 3 to 18). The differ-
ence between groups was 27ppm (95% CI 7 to 50, P<0.01, Fig 5C). The methane levels did not
change significantly from baseline or differ between groups. We tested if the changes in breath
gas levels could be associated with the microbiota composition and found a significant nega-
tive association between increased breath hydrogen and the abundance of Blautia from the
Lachnospiraceae family (P = 0.04).
As some individuals appeared to produce methane in preference to hydrogen, subjects
could be divided into four groups by the levels of gas detectable in breath at baseline, which
allowed more detailed analysis of changes in gas production: hydrogen only, methane only,
Fig 5. Individual variation in detected breath gases and associations to host parameters. A) Subjects could be categorised into four groups
depending on their breath gas: hydrogen & methane>20 ppm (Both), hydrogen & methane< 20 ppm (Neither), only hydrogen> 20 ppm
(Hydrogen) or only methane> 20 ppm (Methane), the data shows both time points; B) Transition between gas groups for subjects following the
intervention. Node sizes and labels indicate the number of subjects in each group. Arrow weights denote the number of subjects changing groups
post-intervention while arrow colours indicate the change in breath hydrogen represented by the transitions. Mean colonic volumes (CV) for each
subgroup are shown; C) Divergence in breath hydrogen (ppm) following the intervention; Associations between gas groupings and D) microbial
diversity (inverse simpson index), E) butyrate (μmol/g wet stool) and F) colonic volume (ml), data for both time points included. BL = baseline,
PI = post-intervention, OF = oligofructose, MD = maltodextrin, H2 = Hydrogen, CH4 = Methane.  p< 0.05,  p< 0.01.
https://doi.org/10.1371/journal.pone.0201410.g005
FODMAPs, microbiota and colonic volume
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both or neither (Fig 5A). At baseline the biggest sub-group (15/37) had neither gas in their
breath above a clinically relevant threshold of 20ppm while 11 had raised hydrogen, 7 raised
methane and 4 had both gases raised. In the maltodextrin-group, all 8 subjects that had
recorded fasting breath hydrogen >20ppm at baseline dropped their levels below this thresh-
old (Fig 5B). In the oligofructose group the trend was opposite where 6 subjects with breath
hydrogen<20ppm at baseline, had breath hydrogen >20ppm after the diet.
Associations between gas groupings and other parameters. Associations were sought
between inter-individual variation in breath gas production and the microbiota composition.
Samples taken from subjects with lower methane levels had significantly lower microbial
diversity compared to those with high levels of breath methane (Fig 5D). Moreover, 10 genus-
level taxa were associated with breath gas groupings (S2 Fig), including increased abundance
of Akkermansia, Ruminococcus and Methanobrevibacter smithii in association with increased
breath methane, and increased abundance of Veillonella with increased breath hydrogen.
In addition to microbial associations, subjects with hydrogen levels >20ppm were observed
to have significantly higher concentrations (p = 0.05) of butyrate in their stool at that time
point (Fig 5E) than those with lower levels. Colonic volumes were also significantly larger in
subjects with above-threshold levels of both hydrogen and methane compared to those where
neither gas reached threshold (P<0.05, Fig 5B & 5F).
Short chain fatty acid concentrations and the microbiota. There was no significant
change in the levels of SFCA post-intervention or between groups (S4 Table). Therefore, we
sought to find associations between the microbiota composition and stool SCFAs. In total 21
genus-level bacterial taxa were found to be significantly associated. Of note, in the family Lach-
nospiraceae, Roseburia was positively associated with increased butyrate (P<0.01) and acetate
(P<0.05), while a member of the same family, Anaerostipes showed negative associations with
isobutyrate (P = 0.09) and valeric acid (P<0.05) (S5 Table).
Correlations between colonic volume and other physiological parameters
Colonic volume did not correlate with breath hydrogen (baseline r = 0.16, P = 0.34, post-inter-
vention r = 0.26, P = 0.12) and only weakly with breath methane (baseline r = 0.32, P = 0.06,
post-intervention r = 0.32, P = 0.06). However, the two breath gases combined correlated
strongly with colonic volume both at baseline (r = 0.43, P<0.01) and post-intervention
(r = 0.58, P<0.001) suggesting a potential biological association between total gas production
and colonic volume (Fig 6A). Colonic volume also correlated significantly with transit score
both at baseline (r = 0.41, P = 0.01) and after intervention (r = 0.37, P<0.05, S3 Fig).
Associations between colonic volume and the microbiota. Given the potential role of
the microbiota in influencing colonic volume both directly, through gas production, and indi-
rectly through other mechanisms, we looked for associations between the microbiota and
colonic volume. Interestingly, colonic volume correlated significantly with overall microbial
diversity at baseline (r = 0.62, adjust.P<0.001) but not post-intervention (r = 0.27, adjust.
P = 0.11, S3 Fig).
We constructed generalised linear models to explore associations between bacterial taxa
and colonic volume, accounting for diet. Beginning at phylum-level, we found that the Actino-
bacteria were positively associated with volume (adjust.P<0.05) while Firmicutes were nega-
tively associated (P<0.05, Fig 6B). To determine the organisms driving these associations we
constructed the same models for both family and genus-level taxa. At family-level, two taxa
from the Firmicutes phylum had significant associations: Lachnospiraceae (adjust.P<0.01)
were negatively associated with volume while uncultured Clostridiaceae (adjust.P<0.05) were
positively associated (Fig 6C). Furthermore, at genus-level the uncultured Clostridium were
FODMAPs, microbiota and colonic volume
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again positively associated (adjust.P<0.05) and Roseburia from the Lachnospiraceae family
were negatively associated (adjust.P<0.05, S3 Fig).
Discussion
The current study is the first to assess colonic contents using MRI, concurrently with abun-
dance of colonic metabolites and a comprehensive characterisation of the intestinal micro-
biota, in order to understand the effect of dietary changes. We showed that a low FODMAP
diet in healthy subjects had an impact on intestinal microbiota composition, levels of breath
hydrogen and colonic volume.
Adherence to the exclusion diet was confirmed by a number of methods including food dia-
ries, supplement use and urinary metabolites. We showed a significant reduction in FODMAP
intake in both groups before supplementation, but also revealed a fall in total carbohydrate
intake accompanied by a reduction in urinary metabolites associated with carbohydrate
metabolism. This could be explained by the avoidance of high FODMAP containing snacks.
While low FODMAP diets aim to replace fermentable non-starch polysaccharides with alter-
natives, this will inevitably lead to some structural changes in overall intake.
The changes in the intestinal microbiota introduced by low FODMAP diets has recently
raised concern, especially the reduction in health-beneficial bifidobacteria[13, 34]. Previously
this was studied only in IBS patients, however we have now replicated this finding in healthy
volunteers, showing that restricting FODMAP intake reduced the relative abundance of Acti-
nobacteria, predominantly Bifidobacteria, in the maltodextrin-group but increased abundance
in the oligofructose-group due to the bifidogenic effect of oligofructose[35, 36]. We also
showed total microbial amount was reduced, reaching significance in the maltodextrin-group,
replicating previous research in IBS patients[13].
The other taxa affected by the dietary intervention included a significant reduction in Clos-
tridia in the oligofructose-group, particularly Lachnospiraceae, many of which are butyrate
producers. This raises the possibility that these taxa may have been displaced by oligofructose-
Fig 6. Colonic volume and associations with breath gas and microbiota. A) Correlation between colonic volume and
total breath gases (hydrogen and methane, ppm) at both time points (rho = 0.51, p< 1 x 10−5); Associations between
colonic volume and the microbiota on B) phylum-level and C) family-level over both time points. BL = baseline,
PI = post-intervention, OF = oligofructose, MD = maltodextrin.
https://doi.org/10.1371/journal.pone.0201410.g006
FODMAPs, microbiota and colonic volume
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induced proliferation of Bifidobacteria. McIntosh et al. reported reductions in Lachnospiraceae
when IBS patients followed a low FODMAP diet[34]. In the maltodextrin-group, an increase
in Ruminococcaceae appeared to accompany the reduction in Bifidobacteria. Such changes
may reflect the effect on the microbial ecosystem as a whole of attempts to alter the abundance
of a single target group. While diverging effects were observed in microbial composition of the
study groups, a twofold increase in Deltaproteobacteria, particularly Bilophila, abundance was
observed in both, possibly indicating an adverse effect of the change in diet. Sulphate reducing
bacteria (SRB), such as Bilophila and Desulfovibrio, are potential pathogens, competing with
other lactate-utilising bacteria such as Anaerostipes in order to produce hydrogen sulphide
which can be toxic to colonocytes[37]. Although the increase in protein intake on the low
FODMAP diet was small, bile tolerant bacteria such as Bilophila have been associated with a
meat based diet so could have been stimulated by substituting carbohydrates with animal pro-
tein[38].
Our breath hydrogen results are consistent with previous studies showing a rise in the
abundance of hydrogen when subjects were supplemented with oligofructose[39] and a fall on
a low FODMAP diet[21]. Interestingly, it has been shown that Lachnospiraceae, notably Blau-
tia, are capable of autotrophic conversion of hydrogen and carbon dioxide to acetate, and this
may partly explain the increased breath hydrogen seen in the oligofructose-group associated
with reduced Blautia abundance.
As there is a recognised heterogeneity in response to low FODMAP diets in IBS patients
[40], we sought to better understand this phenomenon by investigating the inter-individual
response to the intervention in relation to breath gases. We noticed that some subjects with
detectable amounts of breath gases appeared to express either hydrogen or methane gas in
their breath, creating four distinct subgroups allowing us to separate subjects according to
physiological response to the diet. We recognised that the majority of the changes introduced
by the diet were in relation to hydrogen, with all of the baseline hydrogen producers in the
maltodextrin group losing this production post-intervention, whereas in the oligofructose
group, the majority, but not all, either retained or gained hydrogen production.
Although methane production did not change in either group, there was a subset of subjects
with high methane production and distinct characteristics, including higher microbial diver-
sity, higher colonic volume, reduced stool butyrate and increased abundance of methane-pro-
ducing Methanobrevibacter smithii. Surprisingly, methane production was strongly associated
with higher microbial diversity. We hypothesise that the presence of methanogens might facili-
tate distinct niches for elements of the microbiota that would otherwise not exist and could
reflect a diversion of microbial fermentation end-products away from the production of
hydrogen and butyrate, towards methane.
Both hydrogen and methane were shown to be related to higher colonic volumes, possibly
explaining some of the increase in volume in the oligofructose-group. However, there was also
a trend towards increasing volume across all subjects post-intervention, regardless of changes
in gas production, which is unexplained. Previously it was thought that a low FODMAP diet
would reduce microbial fermentation, gas production and therefore colonic volume thereby
relieving pain and bloating in IBS sufferers. We have not found any evidence to support this
hypothesis in healthy subjects, raising the prospect that the success of the diet in IBS patients is
due to an alternative mechanism, perhaps mediated by the effect of bacterial metabolites on
the enteric nervous system. There is clearly a complex interaction between the diet, microbiota
changes, colonic metabolites and GI physiology (Fig 7).
In order to better understand the underlying mechanisms for increased colonic volume, we
looked for associations between the microbiota and colonic volume. Colonic volume was
found to be positively associated with Actinobacteria and negatively associated with
FODMAPs, microbiota and colonic volume
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Lachnospiraceae, mirroring the changes in these taxa seen in subjects after taking oligofructose.
Specifically, increased Roseburia was associated with reduced colonic volume and increased
butyrate and acetate. Butyrate may modulate colonic volume by stimulating increased colonic
muscle tone or contractility, suggesting another potential effect of the microbiota on colonic
volume[41]. While not significant, the slowing of transit could also have contributed to
increased volume.
When analysing the microbiota changes and association with other variables, we employed
a statistical model accounting for confounding factors and with strict adjustment for multiple
comparisons. We also sought to interrogate any positive findings in light of the current litera-
ture and potential biological significance. Nonetheless, it should be emphasised that these anal-
yses were exploratory and should be interpreted cautiously, particularly in view of the limited
sample size.
Our study complements previous work and emphasises the need to consider diet, colonic
environment and intestinal microbiology together in order to interpret their interactions. It
also suggests that low FODMAP diets alleviate GI symptoms through reduced microbial fer-
mentation rather than reducing colonic distension. Further work should focus on how the
alteration in different groups of colonic microbiota induced by a low FODMAP diet changes
specific metabolites which alter colonic function.
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